idw – Informationsdienst Wissenschaft
Nachrichten, Termine, Experten
Nachrichten, Termine, Experten
Swiss scientists have created artificial viruses that can be used to target cancer. These designer viruses alert the immune system and cause it to send killer cells to help fight the tumor. The results, published in the journal Nature Communications, provide a basis for innovative cancer treatments.
Most cancer cells only provoke a limited reaction from the immune system – the body’s defense mechanism – and can thus grow without appreciable resistance. By contrast, viral infections cause the body to release alarm signals, stimulating the immune system to use all available means to fight the invader.
Bolstered defenses
Immunotherapies have been successfully used to treat cancer for many years; they “disinhibit” the body’s defense system and so also strengthen its half-hearted fight against cancer cells. Stimulating the immune system to specifically and wholeheartedly combat cancer cells, however, has remained a distant goal. Researchers lead by Professor Daniel Pinschewer from the University of Basel and Professor Doron Merkler from the University of Geneva have now succeeded in manufacturing innovative designer viruses that could do exactly that.
The researchers built artificial viruses based on lymphocytic choriomeningitis virus (LCMV), which can infect both rodents and humans. Although they were not harmful for mice, they did release the alarm signals typical of viral infections. The virologists also integrated certain proteins into the virus that are otherwise found only in cancer cells. Infection with the designer virus enabled the immune system to recognize these cancer proteins as dangerous.
The unique combination of alarm signals and the cancer cell protein stimulated the immune system to create a powerful army of cytotoxic T-lymphocytes, also known as killer cells, which identified the cancer cells through their protein and successfully destroyed them.
Hope for new cancer treatments
The treatments available to cancer patients have developed enormously in the last few years. However, as the researchers report, current treatments are still inadequate in combating many forms of cancer. “We hope that our new findings and technologies will soon be used in cancer treatments and so help to further increase their success rates,” says the study’s senior author, Professor Daniel Pinschewer.
Original article
Kallert et al.
“Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy”
Nature Communications, doi: 10.1038/NCOMMS15327
Further information
Professor Daniel Pinschewer, University of Basel, Department of Biomedicine, Tel. +41 61 267 32 70, Email: daniel.pinschewer@unibas.ch
Prof. Dr. Doron Merkler, Université de Genève, Département de Pathologie et Immunologie, E-mail : doron.merkler@unige.ch
Criteria of this press release:
Business and commerce, Journalists, Scientists and scholars, Students, Teachers and pupils, all interested persons
Biology, Medicine
transregional, national
Research results, Scientific Publications
English
You can combine search terms with and, or and/or not, e.g. Philo not logy.
You can use brackets to separate combinations from each other, e.g. (Philo not logy) or (Psycho and logy).
Coherent groups of words will be located as complete phrases if you put them into quotation marks, e.g. “Federal Republic of Germany”.
You can also use the advanced search without entering search terms. It will then follow the criteria you have selected (e.g. country or subject area).
If you have not selected any criteria in a given category, the entire category will be searched (e.g. all subject areas or all countries).
